LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, has announced the publication of two pivotal articles in Brain Stimulation journal detailing data from the unipolar cohort of its RECOVER…
Sensorion, a clinical-stage biotechnology company focused on hearing loss therapies, has announced promising safety data from its Phase 1/2 clinical trial, Audiogene, for SENS-501. This gene therapy targets congenital deafness…
MGA Homecare, a prominent provider of home and community-based physical and behavioral health services, has announced its acquisition of Ward Road Pharmacy (WRP), a Long-Term Care Pharmacy (LTCP) and Home…
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company pioneering novel bioelectric medicine with its proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA™) technology, announced a new publication in the Journal of Thoracic and…
Anteris Technologies Global Corp. (“ATGC” or “Anteris”) has successfully closed its initial public offering (IPO) of 14,800,000 shares of its common stock in the U.S., priced at $6.00 per share.…
Fluid Biomed Inc., a clinical-stage medical device company focused on developing lifesaving solutions for vascular disease patients, has successfully raised $27 million in an oversubscribed Series A funding round. The…
Gerresheimer, a leading provider of innovative systems and solutions for the pharma, biotech, and cosmetics industries, announced that the U.S. Food and Drug Administration (FDA) has granted Tentative Approval for…
Celltrion announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions for three of its biosimilar candidates: Eydenzelt® (CT-P42, aflibercept), Stoboclo®…
Cencora, a global healthcare company, has unveiled its new initiative, Accelerate Pharmacy Solutions, aimed at enhancing support for hospital and health system customers. This unified portfolio of services is designed…
BrightPath Bio (Tokyo Stock Exchange Growth 4594), a leader in iPS cell-derived Natural Killer T (NKT) cell therapy, and Cellistic, a pioneer in advanced iPS cell therapy manufacturing, have announced…
Galderma has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the marketing authorization of nemolizumab for the treatment…
Nintx (Next Innovative Therapeutics), a Brazilian biotech company focused on developing treatments for multifactorial diseases using Brazil’s rich biodiversity, has raised an additional US$ 10 million following a US$ 3…